JP2004502756A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004502756A5 JP2004502756A5 JP2002509087A JP2002509087A JP2004502756A5 JP 2004502756 A5 JP2004502756 A5 JP 2004502756A5 JP 2002509087 A JP2002509087 A JP 2002509087A JP 2002509087 A JP2002509087 A JP 2002509087A JP 2004502756 A5 JP2004502756 A5 JP 2004502756A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- halogen
- substituted
- alkoxy
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0017174A GB0017174D0 (en) | 2000-07-12 | 2000-07-12 | Organic compounds |
| GB0023326A GB0023326D0 (en) | 2000-09-22 | 2000-09-22 | Organic compounds |
| PCT/EP2001/007941 WO2002004420A1 (en) | 2000-07-12 | 2001-07-10 | Piperidine coumpounds for use as ccr-3 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004502756A JP2004502756A (ja) | 2004-01-29 |
| JP2004502756A5 true JP2004502756A5 (enExample) | 2005-02-03 |
Family
ID=26244644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002509087A Pending JP2004502756A (ja) | 2000-07-12 | 2001-07-10 | Ｃｃｒ−３インヒビターとして使用するためのピペリジン化合物 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6670379B2 (enExample) |
| EP (1) | EP1303488B1 (enExample) |
| JP (1) | JP2004502756A (enExample) |
| KR (1) | KR20030036603A (enExample) |
| CN (1) | CN1184204C (enExample) |
| AR (1) | AR031597A1 (enExample) |
| AT (1) | ATE447553T1 (enExample) |
| AU (2) | AU2001281972B2 (enExample) |
| BR (1) | BR0112456A (enExample) |
| CA (1) | CA2412941C (enExample) |
| CZ (1) | CZ200375A3 (enExample) |
| DE (1) | DE60140366D1 (enExample) |
| ES (1) | ES2334886T3 (enExample) |
| HU (1) | HUP0301341A2 (enExample) |
| IL (1) | IL153661A0 (enExample) |
| MX (1) | MXPA02012848A (enExample) |
| MY (1) | MY126139A (enExample) |
| NO (1) | NO324760B1 (enExample) |
| NZ (1) | NZ523414A (enExample) |
| PE (1) | PE20020616A1 (enExample) |
| PL (1) | PL358673A1 (enExample) |
| PT (1) | PT1303488E (enExample) |
| SK (1) | SK272003A3 (enExample) |
| TW (1) | TWI227231B (enExample) |
| WO (1) | WO2002004420A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19952147A1 (de) * | 1999-10-29 | 2001-05-03 | Boehringer Ingelheim Pharma | Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| EP1330436B1 (en) * | 2000-10-09 | 2010-06-30 | Novartis AG | N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3-3 receptor antagonists |
| GB0114699D0 (en) | 2001-06-15 | 2001-08-08 | Novartis Ag | Organic compounds |
| US8371292B2 (en) * | 2003-09-16 | 2013-02-12 | Nycomed Gmbh | Use of ciclesonide for the treatment of respiratory diseases |
| US9227978B2 (en) | 2013-03-15 | 2016-01-05 | Araxes Pharma Llc | Covalent inhibitors of Kras G12C |
| TW201524952A (zh) * | 2013-03-15 | 2015-07-01 | Araxes Pharma Llc | Ｋｒａｓ ｇ１２ｃ之共價抑制劑 |
| JO3805B1 (ar) | 2013-10-10 | 2021-01-31 | Araxes Pharma Llc | مثبطات كراس جي12سي |
| MX382355B (es) | 2015-04-10 | 2025-03-13 | Araxes Pharma Llc | Compuestos de quinazolina sustituidos y métodos de uso de los mismos. |
| EP3283462B1 (en) | 2015-04-15 | 2020-12-02 | Araxes Pharma LLC | Fused-tricyclic inhibitors of kras and methods of use thereof |
| US10144724B2 (en) | 2015-07-22 | 2018-12-04 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use thereof |
| EP3356351A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| WO2017058728A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| US10689356B2 (en) | 2015-09-28 | 2020-06-23 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| EP3356354A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| EP3356349A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| WO2017058792A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| EP3356347A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| EP3377481A1 (en) | 2015-11-16 | 2018-09-26 | Araxes Pharma LLC | 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof |
| US10646488B2 (en) | 2016-07-13 | 2020-05-12 | Araxes Pharma Llc | Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof |
| EP3519402A1 (en) | 2016-09-29 | 2019-08-07 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| US10377743B2 (en) | 2016-10-07 | 2019-08-13 | Araxes Pharma Llc | Inhibitors of RAS and methods of use thereof |
| WO2018140513A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer |
| US11136308B2 (en) | 2017-01-26 | 2021-10-05 | Araxes Pharma Llc | Substituted quinazoline and quinazolinone compounds and methods of use thereof |
| EP3573954A1 (en) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | Fused bicyclic benzoheteroaromatic compounds and methods of use thereof |
| CN110382482A (zh) | 2017-01-26 | 2019-10-25 | 亚瑞克西斯制药公司 | 稠合的杂-杂二环化合物及其使用方法 |
| US11358959B2 (en) | 2017-01-26 | 2022-06-14 | Araxes Pharma Llc | Benzothiophene and benzothiazole compounds and methods of use thereof |
| CN110869358A (zh) | 2017-05-25 | 2020-03-06 | 亚瑞克西斯制药公司 | Kras的共价抑制剂 |
| JP2020521741A (ja) | 2017-05-25 | 2020-07-27 | アラクセス ファーマ エルエルシー | がんの処置のための化合物およびその使用の方法 |
| CN110831933A (zh) | 2017-05-25 | 2020-02-21 | 亚瑞克西斯制药公司 | 喹唑啉衍生物作为突变kras、hras或nras的调节剂 |
| BR112021001709A2 (pt) | 2018-08-01 | 2021-05-04 | Araxes Pharma Llc | compostos espiro heterocíclicos e métodos de uso dos mesmos para o tratamento de câncer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2296314A1 (en) * | 1997-07-25 | 1999-02-04 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
| IL125658A0 (en) | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
| US6339087B1 (en) | 1997-08-18 | 2002-01-15 | Syntex (U.S.A.) Llc | Cyclic amine derivatives-CCR-3 receptor antagonists |
| PT1131291E (pt) * | 1998-11-17 | 2005-01-31 | Hoffmann La Roche | Antagonistas iii do receptor 4-aroil-piperidin-ccr-3 |
| AU3126700A (en) * | 1998-12-18 | 2000-07-03 | Du Pont Pharmaceuticals Company | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| EE200100502A (et) * | 1999-03-26 | 2002-12-16 | Astrazeneca Ab | Ühendid |
-
2001
- 2001-07-09 TW TW090116691A patent/TWI227231B/zh not_active IP Right Cessation
- 2001-07-10 MX MXPA02012848A patent/MXPA02012848A/es active IP Right Grant
- 2001-07-10 DE DE60140366T patent/DE60140366D1/de not_active Expired - Lifetime
- 2001-07-10 AU AU2001281972A patent/AU2001281972B2/en not_active Ceased
- 2001-07-10 AU AU8197201A patent/AU8197201A/xx active Pending
- 2001-07-10 KR KR10-2003-7000445A patent/KR20030036603A/ko not_active Withdrawn
- 2001-07-10 EP EP01960488A patent/EP1303488B1/en not_active Expired - Lifetime
- 2001-07-10 JP JP2002509087A patent/JP2004502756A/ja active Pending
- 2001-07-10 SK SK27-2003A patent/SK272003A3/sk not_active Application Discontinuation
- 2001-07-10 CA CA2412941A patent/CA2412941C/en not_active Expired - Fee Related
- 2001-07-10 NZ NZ523414A patent/NZ523414A/en unknown
- 2001-07-10 CN CNB018126111A patent/CN1184204C/zh not_active Expired - Fee Related
- 2001-07-10 BR BR0112456-0A patent/BR0112456A/pt not_active IP Right Cessation
- 2001-07-10 MY MYPI20013274A patent/MY126139A/en unknown
- 2001-07-10 CZ CZ200375A patent/CZ200375A3/cs unknown
- 2001-07-10 AR ARP010103261A patent/AR031597A1/es unknown
- 2001-07-10 PT PT01960488T patent/PT1303488E/pt unknown
- 2001-07-10 IL IL15366101A patent/IL153661A0/xx unknown
- 2001-07-10 US US10/332,642 patent/US6670379B2/en not_active Expired - Fee Related
- 2001-07-10 ES ES01960488T patent/ES2334886T3/es not_active Expired - Lifetime
- 2001-07-10 AT AT01960488T patent/ATE447553T1/de not_active IP Right Cessation
- 2001-07-10 PE PE2001000683A patent/PE20020616A1/es not_active Application Discontinuation
- 2001-07-10 PL PL01358673A patent/PL358673A1/xx not_active Application Discontinuation
- 2001-07-10 HU HU0301341A patent/HUP0301341A2/hu unknown
- 2001-07-10 WO PCT/EP2001/007941 patent/WO2002004420A1/en not_active Ceased
-
2003
- 2003-01-10 NO NO20030135A patent/NO324760B1/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2412941A1 (en) | Piperidine compounds for use as ccr-3 inhibitors | |
| CA2694270A1 (en) | Substituted aryloxazoles and the use thereof | |
| JP2004501930A5 (enExample) | ||
| CA2681972A1 (en) | Substituted dibenzoic acid derivatives and use thereof | |
| CN109983007A (zh) | 酰胺类衍生物抑制剂及其制备方法和应用 | |
| RU2007148994A (ru) | Композиции и способы лечения заболевания сетчатки | |
| CA2626477A1 (en) | Dicarboxylic acid derivatives and their use | |
| CN114401964A (zh) | 一类具有brd4抑制活性的化合物、其制备方法及用途 | |
| RU2018120242A (ru) | Хинолиновые соединения, способы их получения и их применения в качестве лекарственного средства, ингибирующего транспортер уратов | |
| CA2671071A1 (en) | Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof | |
| JP2010510999A5 (enExample) | ||
| RU2003117476A (ru) | Аминотиазолы и их применение в качестве антагонистов рецептора аденозина | |
| JP2007516206A5 (enExample) | ||
| CA2492718A1 (en) | Prodrugs of proton pump inhibitors | |
| JP2016531126A5 (enExample) | ||
| CA2626451A1 (en) | Cyclopropylacetic acid derivatives and use thereof | |
| CA2626454A1 (en) | Difluorophenol derivatives and their use | |
| RU2002110115A (ru) | Бензопирановое производное | |
| JP2002514649A5 (enExample) | ||
| CA2578596A1 (en) | Substituted phenylaminothiazoles and their use | |
| JP2006523698A5 (enExample) | ||
| RU2314292C2 (ru) | Производные азетидина в качестве антагонистов ccr-3 рецептора | |
| CA2626464A1 (en) | Tetrazol derivatives and their use for the treatment of cardiovascular diseases | |
| JP2007522159A5 (enExample) | ||
| CA2626402A1 (en) | Potassium channel inhibitors |